GGrantIndex
Sort

21,281 grants matching influenza

ARRA: Process Development and Manufacture of Universal Influenza Vaccine

$13,400,000
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2010 · AI

Vanderbilt Vaccine and Treatment Evaluation Unit

$13,319,092
Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI

Development of Human Anti-Influenza Monoclonal Antibodies for Treatment of Flu

$13,246,602
Jaap Goudsmit · Janessen Vaccines And Prevention, Bv · N01 · FY2009 · AI

Regulatory Support Services

$13,096,597
Laura McNay · National Institute Of Allergy And Infectious Diseases · ZID · FY2011 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$13,039,166
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2019 · AI

Center of Excellence for Influenza Research and Surveillance

$13,021,810
St. Jude Children'S Research Hospital · N01 · FY2008 · AI

Washington National Primate Research Center

$12,924,750
David M Anderson · University Of Washington · P51 · FY2014 · OD

Center of Excellence for Influenza Research and Surveillance

$12,868,722
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2012 · AI

Washington National Primate Research Center

$12,859,589
David M Anderson · University Of Washington · P51 · FY2016 · OD

Regulatory Support Services

$12,854,530
John Tierney · National Institute Of Allergy And Infectious Diseases · ZID · FY2024 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA VACCINE RESEARCH

$12,837,354
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2025 · AI

Washington National Primate Research Center

$12,795,503
David M Anderson · University Of Washington · P51 · FY2015 · OD

National Emerging Infectious Diseases Laboratories Operations

$12,697,405
Ronald B Corley · Boston University Medical Campus · UC7 · FY2015 · AI

Vanderbilt Vaccine and Treatment Evaluation Unit

$12,509,936
Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2020 · AI

Impaired human innate immune cell function in the elderly and immunosuppressed

$12,439,964
Erol Fikrig · Yale University · N01 · FY2011 · AI

NIAID Centers of Excellence for Influenza Research and Response

$12,408,897
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2024 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$12,362,465
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2016 · AI

CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations

$12,275,590
Ted Ross · University Of Georgia · N01 · FY2021 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM

$11,979,672
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2020 · AI

Moodeling Immunity for Biodefense: influenza virus

$11,916,323
Hulin Wu · University Of Rochester · N01 · FY2010 · AI

CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)

$11,796,860
Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2017 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH

$11,756,332
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2022 · AI

Development/production of universal influenza vaccines

$11,743,293
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2014 · AI

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$11,669,860
David S Stephens · Emory University · UM1 · FY2022 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE

$11,506,068
Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2020 · AI